Show simple item record

dc.contributor.authorEkmekci, Ahmet
dc.contributor.authorCicek, Gokhan
dc.contributor.authorUluganyan, MAHMUT
dc.contributor.authorGungor, Baris
dc.contributor.authorOsman, Faizel
dc.contributor.authorOzcan, Kazim Serhan
dc.contributor.authorBozbay, Mehmet
dc.contributor.authorErtas, Gokhan
dc.contributor.authorZencirci, Aycan
dc.contributor.authorSayar, Nurten
dc.contributor.authorEren, Mehmet
dc.date.accessioned2019-12-23T20:59:44Z
dc.date.available2019-12-23T20:59:44Z
dc.date.issued2014-02-01
dc.identifier.urihttps://hdl.handle.net/20.500.12645/10767
dc.description.abstractAdmission hyperglycemia is associated with high inhospital and long-term adverse events in patients that undergo primary percutaneous coronary intervention (PCI). We aimed to evaluate whether hyperglycemia predicts inhospital mortality. We prospectively analyzed 503 consecutive patients. The patients were divided into tertiles according to the admission glucose levels. Tertile I: glucose 145 mg/dL (n = 169). Inhospital mortality was 0 in tertile I, 2 in tertile II, and 9 in tertile III (P < .02). Cardiogenic shock occurred more frequently in tertile III compared to tertiles I and II (10% vs 4.1% and 0.6%, respectively, P = .01). Multivariate logistic regression analysis revealed that patients in tertile III had significantly higher risk of inhospital major adverse cardiac events compared to patients in tertile I (odds ratio: 9.55, P < .02). Admission hyperglycemia predicts inhospital adverse cardiac events in mortality and acute ST-segment elevation myocardial infarction in patients that underwent primary PCI.
dc.language.isoen
dc.subjectEkmekci A., Cicek G., Uluganyan M., Gungor B., Osman F., Ozcan K. S. , Bozbay M., Ertas G., Zencirci A., Sayar N., et al., -Admission Hyperglycemia Predicts Inhospital Mortality and Major Adverse Cardiac Events After Primary Percutaneous Coronary Intervention in Patients Without Diabetes mellitus-, ANGIOLOGY, cilt.65, ss.154-159, 2014
dc.titleAdmission Hyperglycemia Predicts Inhospital Mortality and Major Adverse Cardiac Events After Primary Percutaneous Coronary Intervention in Patients Without Diabetes mellitus
dc.typeArticle
dc.identifier.wosWOS:000337970700013
dc.identifier.scopus84891856747
dc.identifier.doi10.1177/0003319713488930
dc.identifier.pubmed23657174
local.publication.isinternational1


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record